journal article·2019-12

Selective and sensitive detection and quantification of human carboxylesterase 1 by a ratiometric fluorescence probe

Zhao-ming Liu, Hui-jie Du, Ting-qiang Wang, Yan-nan Ma, Jun-ru Liu, Mao-cai Yan, Hui-yun Wang

Dyes and Pigments· Volume 171
Publisher page

Abstract

Abstract A novel ratiometric fluorescent probe derived from 2-(2′-hydroxy-3′-methoxyphenyl) benzothiazole (HMBT) for human carboxylesterase 1 (hCES1) has been synthesized and well characterized. The probe was designed by modulating the excited state intramolecular proton transfer (ESIPT) emission of HMBT via introducing of an octanoyl group. Under physiological conditions, the probe displayed satisfying stability with very low background fluorescence signal at 489 nm, but it could be selectively hydrolyzed by hCES1 to release its metabolite HMBT which brings remarkable changes in fluorescence spectrum. The newly designed probe exhibited excellent selectivity towards hCES1 over other enzymes, while the interference of endogenous chemicals was negligible. The probe can be used for accurately measuring the actual activities of hCES1 in complex biological samples. The potential biological applications of the probe including inhibitor screening, quantification of hCES1 in serum, as well as fluorescence imaging in vivo, have been demonstrated.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cholinesterase and Neurodegenerative Diseases · Electrochemical sensors and biosensors · Molecular Sensors and Ion Detection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (35)

Show source-provided references
1. Mammalian carboxylesterases: from drug targets to protein therapeutics10.1016/S1359-6446(05)03383-0 ↗
2. Human carboxylesterases and their role in xenobiotic and endobiotic metabolism10.1002/jbt.20178 ↗
3. Current progress on esterases: from molecular structure to function10.1124/dmd.30.5.488 ↗
4. Proficient metabolism of irinotecan by a human intestinal carboxylesterase
5. Structure, function and regulation of carboxylesterases10.1016/j.cbi.2006.07.001 ↗
6. The mammalian carboxylesterases: from molecules to functions10.1146/annurev.pharmtox.38.1.257 ↗
7. Simultaneous absolute protein quantification of carboxylesterases 1 and 2 in human liver tissue fractions using liquid chromatography-tandem mass spectrometry10.1124/dmd.112.045054 ↗
8. Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver10.1124/dmd.109.028209 ↗
9. Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition10.1016/S1074-5521(03)00071-1 ↗
10. Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil10.1016/j.jmb.2005.07.016 ↗
11. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 210.1124/dmd.111.039628 ↗
12. Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages10.1016/j.bbalip.2008.07.005 ↗
13. Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin10.1016/j.bcp.2008.10.005 ↗
14. Methylphenidate is stereoselectively hydrolyzed by human carboxylesterase CES1A110.1124/jpet.104.067116 ↗
15. Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 110.1016/j.jmb.2006.08.025 ↗
16. Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids10.1016/j.bbalip.2009.09.002 ↗
17. Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia10.1002/hep.25961 ↗
18. Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis10.1002/hep.26714 ↗
19. Functional polymorphisms in carboxylesterase1A2 (CES1A2) gene involves specific protein 1 (Sp1) binding sites10.1016/j.bbrc.2008.02.120 ↗
20. Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions10.1016/j.tox.2010.01.009 ↗
21. Activity-based probes: discovering new biology and new drug targets10.1039/C0CS00004C ↗
22. Strategies for in vivo imaging of enzyme activity: an overview and recent advances10.1039/c1cs15035a ↗
23. Reaction-based small-molecule fluorescent probes for chemoselective bioimaging10.1038/nchem.1500 ↗
24. A ratiometric fluorescent sensor for highly selective detection of human carboxylesterase 2 and its application in living cells10.1016/j.snb.2014.08.066 ↗
25. Excited-state intramolecular proton-transfer (ESIPT) based fluorescence sensors and imaging agents10.1039/C8CS00185E ↗
26. Development of amide-based fluorescent probes for selective measurement of carboxylesterase 1 activity in tissue extracts10.1016/j.ab.2017.10.014 ↗
27. A highly selective ratiometric fluorescent probe for in vitro monitoring and cellular imaging of human carboxylesterase 110.1016/j.bios.2014.01.049 ↗
28. A bioluminescent sensor for highly selective and sensitive detection of human carboxylesterase 1 in complex biological samples10.1039/C5CC09874B ↗
29. A highly selective marker reaction for measuring the activity of human carboxylesterase 1 in complex biological samples10.1039/C5RA23614B ↗
30. Fluorogenic probes for disease-relevant enzymes10.1039/C7CS00907K ↗
31. Conjugate addition/cyclization sequence enables selective and simultaneous fluorescence detection of cysteine and homocysteine10.1002/anie.201103759 ↗
32. Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 110.1016/j.ijbiomac.2018.09.178 ↗
33. Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide10.1124/jpet.104.081265 ↗
34. Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor10.3109/00498251003706598 ↗
35. Ultrafast excited-state proton transfer and subsequent coherent skeletal motion of 2-(2′-hydroxyphenyl)benzothiazole10.1063/1.481711 ↗